p57-discordant villi in hydropic products of conception: a clinicopathological study of 70 cases.

[1]  U. Surti,et al.  A novel NLRP7 protein-truncating mutation associated with discordant and divergent p57 immunostaining in diploid biparental and triploid digynic moles , 2020, Virchows Archiv.

[2]  P. Hui,et al.  Paternal uniparental isodisomy of tyrosine hydroxylase locus at chromosome 11p15.4: spectrum of phenotypical presentations simulating hydatidiform moles , 2019, Modern Pathology.

[3]  B. Ronnett.  Hydatidiform Moles: Ancillary Techniques to Refine Diagnosis. , 2018, Archives of pathology & laboratory medicine.

[4]  U. Surti,et al.  Maternal GRB10 microdeletion is a novel cause of cystic placenta: Spectrum of genomic changes in the etiology of enlarged cystic placenta. , 2017, Placenta.

[5]  M. Fritsch,et al.  Placental Mesenchymal Dysplasia without Fetal Development in a Twin Gestation: A Case Report and Review of the Spectrum of Androgenetic Biparental Mosaicism , 2015, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[6]  D. Heller,et al.  Placental mesenchymal dysplasia. , 2014, Archives of pathology & laboratory medicine.

[7]  K. Murphy,et al.  Characteristics of hydatidiform moles: analysis of a prospective series with p57 immunohistochemistry and molecular genotyping , 2014, Modern Pathology.

[8]  Lisa M Haley,et al.  Characterization of Androgenetic/Biparental Mosaic/Chimeric Conceptions, Including Those With a Molar Component: Morphology, p57 Immnohistochemistry, Molecular Genotyping, and Risk of Persistent Gestational Trophoblastic Disease , 2013, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[9]  R. Kapur,et al.  Placental Mesenchymal Dysplasia. , 2013, Surgical pathology clinics.

[10]  L. Bolund,et al.  Mosaics and moles , 2011, European Journal of Human Genetics.

[11]  K. Murphy,et al.  Molecular genotyping of hydatidiform moles: analytic validation of a multiplex short tandem repeat assay. , 2009, The Journal of molecular diagnostics : JMD.

[12]  A. Vasiljevic,et al.  IMMUNOHISTOCHEMICAL EXPRESSION OF P57 IN PLACENTAL VASCULAR PROLIFERATIVE DISORDERS OF PRETERM AND TERM PLACENTAS , 2009, Fetal and pediatric pathology.

[13]  C. Bifulco,et al.  Genotypic Analysis of Hydatidiform Mole: An Accurate and Practical Method of Diagnosis , 2008, The American journal of surgical pathology.

[14]  W. Lam,et al.  Placental mesenchymal dysplasia associated with fetal overgrowth and mosaic deletion of the maternal copy of 11p15.5 , 2007, American journal of medical genetics. Part A.

[15]  A. Innes,et al.  Origin and outcome of pregnancies affected by androgenetic/biparental chimerism. , 2007, Human reproduction.

[16]  T. Kinoshita,et al.  Placental mesenchymal dysplasia , 2007, The journal of obstetrics and gynaecology research.

[17]  L. Chiriboga,et al.  Multiplex short tandem repeat DNA analysis confirms the accuracy of p57(KIP2) immunostaining in the diagnosis of complete hydatidiform mole. , 2006, Human pathology.

[18]  I. Hammond,et al.  Intraoperative assessment of ovarian tumors: a 5-year review with assessment of discrepant diagnostic cases. , 2006, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[19]  U. Surti,et al.  Persistent Gestational Trophoblastic Disease After an Androgenetic/Biparental Fetal Chimera: A Case Report and Review , 2006, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[20]  C. Livasy,et al.  Androgenetic/biparental mosaicism causes placental mesenchymal dysplasia , 2005, Journal of Medical Genetics.

[21]  Larissa V Furtado,et al.  Diagnostic utility of microsatellite genotyping for molar pregnancy testing. , 2013, Archives of pathology & laboratory medicine.

[22]  U. Surti,et al.  P57KIP2 immunostaining and molecular cytogenetics: combined approach aids in diagnosis of morphologically challenging cases with molar phenotype and in detecting androgenetic cell lines in mosaic/chimeric conceptions. , 2008, Human pathology.